vs

Side-by-side financial comparison of INTERNATIONAL BANCSHARES CORP (IBOC) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.

USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($226.2M vs $217.7M, roughly 1.0× INTERNATIONAL BANCSHARES CORP). INTERNATIONAL BANCSHARES CORP runs the higher net margin — 62.3% vs 0.1%, a 62.3% gap on every dollar of revenue. On growth, INTERNATIONAL BANCSHARES CORP posted the faster year-over-year revenue change (4.5% vs -10.0%). Over the past eight quarters, USANA HEALTH SCIENCES INC's revenue compounded faster (3.1% CAGR vs 2.8%).

International Bancshares Corporation is a bank holding company based in Laredo, Texas whose primary subsidiary is International Bank of Commerce. Through its bank subsidiaries, it has 217 banking offices and 315 automated teller machines serving 88 communities in the U.S. states of Texas and Oklahoma.

Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.

IBOC vs USNA — Head-to-Head

Bigger by revenue
USNA
USNA
1.0× larger
USNA
$226.2M
$217.7M
IBOC
Growing faster (revenue YoY)
IBOC
IBOC
+14.5% gap
IBOC
4.5%
-10.0%
USNA
Higher net margin
IBOC
IBOC
62.3% more per $
IBOC
62.3%
0.1%
USNA
Faster 2-yr revenue CAGR
USNA
USNA
Annualised
USNA
3.1%
2.8%
IBOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBOC
IBOC
USNA
USNA
Revenue
$217.7M
$226.2M
Net Profit
$106.9M
$180.0K
Gross Margin
78.2%
Operating Margin
62.8%
1.7%
Net Margin
62.3%
0.1%
Revenue YoY
4.5%
-10.0%
Net Profit YoY
-7.1%
-74.0%
EPS (diluted)
$1.71
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBOC
IBOC
USNA
USNA
Q4 25
$217.7M
$226.2M
Q3 25
$218.1M
$213.7M
Q2 25
$208.2M
$235.8M
Q1 25
$198.2M
$249.5M
Q4 24
$208.3M
$213.6M
Q3 24
$211.8M
$200.2M
Q2 24
$207.8M
$212.9M
Q1 24
$205.8M
Net Profit
IBOC
IBOC
USNA
USNA
Q4 25
$106.9M
$180.0K
Q3 25
$108.4M
$-6.5M
Q2 25
$100.1M
$9.7M
Q1 25
$96.9M
$9.4M
Q4 24
$115.1M
$4.5M
Q3 24
$99.8M
$10.6M
Q2 24
$97.0M
$10.4M
Q1 24
$97.3M
Gross Margin
IBOC
IBOC
USNA
USNA
Q4 25
78.2%
Q3 25
77.2%
Q2 25
78.7%
Q1 25
79.0%
Q4 24
82.0%
Q3 24
80.4%
Q2 24
81.1%
Q1 24
Operating Margin
IBOC
IBOC
USNA
USNA
Q4 25
62.8%
1.7%
Q3 25
62.6%
0.6%
Q2 25
60.5%
7.1%
Q1 25
61.1%
6.3%
Q4 24
64.2%
3.8%
Q3 24
60.0%
7.8%
Q2 24
60.1%
8.4%
Q1 24
59.9%
Net Margin
IBOC
IBOC
USNA
USNA
Q4 25
62.3%
0.1%
Q3 25
49.7%
-3.1%
Q2 25
48.1%
4.1%
Q1 25
48.9%
3.8%
Q4 24
71.5%
2.1%
Q3 24
47.1%
5.3%
Q2 24
46.7%
4.9%
Q1 24
47.3%
EPS (diluted)
IBOC
IBOC
USNA
USNA
Q4 25
$1.71
$-0.10
Q3 25
$1.74
$-0.36
Q2 25
$1.61
$0.52
Q1 25
$1.56
$0.49
Q4 24
$1.85
$0.23
Q3 24
$1.60
$0.56
Q2 24
$1.56
$0.54
Q1 24
$1.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBOC
IBOC
USNA
USNA
Cash + ST InvestmentsLiquidity on hand
$5.5B
$158.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.3B
Total Assets
$16.6B
$742.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBOC
IBOC
USNA
USNA
Q4 25
$5.5B
$158.4M
Q3 25
$5.6B
$145.3M
Q2 25
$5.8B
$151.3M
Q1 25
$5.6B
$179.6M
Q4 24
$5.4B
$181.8M
Q3 24
$5.8B
$364.9M
Q2 24
$5.7B
$332.4M
Q1 24
$5.7B
Stockholders' Equity
IBOC
IBOC
USNA
USNA
Q4 25
$3.3B
Q3 25
$3.1B
$528.1M
Q2 25
$3.0B
$531.1M
Q1 25
$2.9B
$529.8M
Q4 24
$2.8B
$532.1M
Q3 24
$2.7B
$533.1M
Q2 24
$2.6B
$512.2M
Q1 24
$2.5B
Total Assets
IBOC
IBOC
USNA
USNA
Q4 25
$16.6B
$742.9M
Q3 25
$16.6B
$726.6M
Q2 25
$16.5B
$734.5M
Q1 25
$16.3B
$746.6M
Q4 24
$15.7B
$748.2M
Q3 24
$15.9B
$671.3M
Q2 24
$15.5B
$631.4M
Q1 24
$15.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBOC
IBOC
USNA
USNA
Operating Cash FlowLast quarter
$491.1M
Free Cash FlowOCF − Capex
$472.9M
FCF MarginFCF / Revenue
217.2%
Capex IntensityCapex / Revenue
8.3%
Cash ConversionOCF / Net Profit
4.59×
TTM Free Cash FlowTrailing 4 quarters
$809.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBOC
IBOC
USNA
USNA
Q4 25
$491.1M
Q3 25
$115.2M
$-2.0M
Q2 25
$95.5M
$12.2M
Q1 25
$140.5M
$15.5M
Q4 24
$473.9M
$5.8M
Q3 24
$116.5M
$29.5M
Q2 24
$107.2M
$8.0M
Q1 24
$135.4M
Free Cash Flow
IBOC
IBOC
USNA
USNA
Q4 25
$472.9M
Q3 25
$112.2M
$-5.2M
Q2 25
$91.6M
$7.2M
Q1 25
$133.1M
$12.7M
Q4 24
$459.8M
$4.0M
Q3 24
$109.6M
$27.1M
Q2 24
$104.9M
$5.3M
Q1 24
$128.9M
FCF Margin
IBOC
IBOC
USNA
USNA
Q4 25
217.2%
Q3 25
51.5%
-2.4%
Q2 25
44.0%
3.0%
Q1 25
67.1%
5.1%
Q4 24
220.8%
1.9%
Q3 24
51.7%
13.6%
Q2 24
50.5%
2.5%
Q1 24
62.6%
Capex Intensity
IBOC
IBOC
USNA
USNA
Q4 25
8.3%
Q3 25
1.3%
1.5%
Q2 25
1.9%
2.1%
Q1 25
3.7%
1.1%
Q4 24
6.8%
0.8%
Q3 24
3.3%
1.2%
Q2 24
1.1%
1.3%
Q1 24
3.2%
Cash Conversion
IBOC
IBOC
USNA
USNA
Q4 25
4.59×
Q3 25
1.06×
Q2 25
0.95×
1.27×
Q1 25
1.45×
1.65×
Q4 24
4.12×
1.29×
Q3 24
1.17×
2.78×
Q2 24
1.11×
0.77×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons